Specialty Drug Pipeline Reviews to help you
Control Medical Drug Spend

Sign up for RJ Health Drug Alerts below to access our collection of reviews.

If you are already a Drug Alerts subscriber, simply re-enter your email to be redirected.

Our current collection of specialty drug pipeline reviews available to Drug Alerts subscribers includes:

Burosumab-twza (Crysvita®)

Orginal FDA Approval: April 17, 2018
Last updated: March 14, 2018

Cemiplimab-rwlc (Libtayo®)

Original FDA Approval: September 28, 2018
Last Updated: October 15, 2018

Erenumab-aooe (Aimovig™)

Original FDA Approval: May 17, 2018
Last Updated: March 9, 2018

Fremanezumab-vfrm (Ajovy™)

Original FDA Approval: September 14, 2018
Last Updated: September 24, 2018

Ibalizumab-uiyk (Trogarzo™)

Original FDA Approval: March 6, 2018
Last Updated: March 6, 2018

Inotersen sodium (Tegsedi™)

Original FDA Approval: October 5, 2018
Last Updated: October 16, 2018

Lanadelumab-flyo (Takhzyro™)

Original FDA Approval: August 23, 2018
Last Updated: August 27, 2018

Mogamulizumab-kpkc (Poteligeo®)

Original FDA Approval: August 8, 2018
Last Updated: August 10, 2018

Moxetumomab pasudotox-tdfk (Lumoxiti™)

Original FDA Approval: September 13, 2018
Last Updated: September 21, 2018

Patisiran (Onpattro™)

Original FDA Approval: August 10, 2018
Last Updated: August 13, 2018

Pegfilgrastim-cbqv (Udenyca™)

Original FDA Approval: November 2, 2018
Last Updated: November 5,2018

Rituxan (Rituximab) Biosimilars

Original FDA Approval: November 26, 1997
Last Updated: December 7, 2017

Tildrakizumab-asmn (Ilumya™)

Original FDA Approval: March 20, 2018
Last Updated: February 28, 2018

Trastuzumab (Herceptin®) Biosimilars

Original FDA Approval: September 25, 1998
Last Updated: February 26, 2018

Volanesorsen (Waylivra)

Phase 3 Clinical Development: Sept 25, 1998
Last Updated: July 25, 2018

Venetoclax (Venclexta ®)

Original FDA Approval: April 11, 2016
Last Updated: January 17, 2019

Sacituzumab Govitecan

Complete Response Letter: January 17, 2019
Last Updated: January 17, 2019

Caplacizumab (Cablivi™)

PDUFA: February 2, 2018
Last Updated: January 28, 2019